US Stock MarketDetailed Quotes
IDXAF IDEX BIOMETRICS ASA
- 0.030000
- 0.0000000.00%
15min DelayClose Jan 8 16:00 ET
8.38MMarket Cap-300P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.030000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)279.40MShares0.16510052wk High0.43P/B7.50MFloat Cap0.03000052wk Low--Dividend TTM249.88MShs Float0.422900Historical High--Div YieldTTM0.00%Amplitude0.030000Historical Low--Avg Price1Lot Size
IDEX BIOMETRICS ASA Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 20.86%-7.14M | -6.60%-8.97M | -13.94%-31.37M | 12.94%-6.68M | -15.28%-7.26M | -34.93%-9.02M | -22.30%-8.41M | -18.20%-27.53M | -21.10%-7.67M | -3.50%-6.3M |
| Net income from continuing operations | 19.15%-7.47M | 10.93%-7.23M | -0.73%-32.7M | 38.32%-6.31M | -20.82%-9.02M | -27.75%-9.24M | -7.86%-8.12M | -20.89%-32.46M | -42.02%-10.23M | -9.92%-7.47M |
| Depreciation and amortization | 20.66%403K | -7.86%340K | -24.97%1.35M | -26.17%316K | -27.61%333K | -27.39%334K | -18.72%369K | 4.83%1.8M | -2.51%428K | 6.98%460K |
| Other non cash items | --1K | ---1K | --1K | ---1.87M | 1,798.51%1.27M | ---- | ---- | ---- | ---- | 231.37%67K |
| Change In working capital | 49.78%-345K | -70.89%-2.45M | -799.23%-2.71M | -83.49%196K | -266.37%-188K | -31.11%-687K | -270.10%-1.44M | 143.69%388K | 827.34%1.19M | 115.52%113K |
| -Change in receivables | 277.88%185K | 121.58%109K | -74.52%-548K | -360.47%-198K | 840.00%259K | 44.09%-104K | -910.00%-505K | 24.15%-314K | 80.45%-43K | 51.39%-35K |
| -Change in inventory | -8,715.38%-1.15M | -12.50%-873K | -757.33%-3.22M | -979.43%-1.52M | -851.58%-904K | 85.06%-13K | -1,392.31%-776K | -169.78%-375K | -338.98%-141K | 32.14%-95K |
| -Change in payables and accrued expense | 75.00%-55K | -481.40%-492K | 1,518.87%858K | 1,455.17%902K | 112.77%47K | -154.73%-220K | 430.77%129K | -62.41%53K | 41.46%58K | 17.67%-368K |
| -Change in other working capital | 291.71%671K | -321.83%-1.2M | -81.25%192K | -22.77%1.01M | -32.90%410K | 46.40%-350K | -14.98%-284K | 315.13%1.02M | 429.44%1.31M | 985.51%611K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 20.88%-7.14M | -6.61%-8.97M | -13.94%-31.37M | 12.95%-6.68M | -15.28%-7.26M | -34.93%-9.02M | -22.30%-8.41M | -18.20%-27.53M | -21.10%-7.67M | -3.50%-6.3M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -303.03%-133K | 415.38%123K | -12.59%-161K | -325.00%-18K | -57.78%-71K | 8.33%-33K | 44.29%-39K | 38.36%-143K | 103.39%8K | -850.00%-45K |
| Net PPE purchase and sale | -272.55%-190K | 135.29%18K | -89.36%-267K | -341.67%-53K | -460.00%-112K | -30.77%-51K | 27.14%-51K | 7.24%-141K | 80.33%-12K | 60.78%-20K |
| Net intangibles purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other investing changes | 300.00%4K | 116.67%13K | 176.92%10K | -125.00%-4K | 128.00%7K | --1K | 250.00%6K | -117.33%-13K | 1,500.00%16K | -144.64%-25K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -303.03%-133K | 412.82%122K | -11.89%-160K | -312.50%-17K | -57.78%-71K | 8.33%-33K | 44.29%-39K | 38.36%-143K | 103.39%8K | -850.00%-45K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 10,628.16%10.84M | -57.87%99K | -74.19%13.98M | -51.87%13.72M | 258.33%129K | -230.38%-103K | -99.08%235K | 210.52%54.15M | 263.90%28.49M | 118.09%36K |
| Net issuance payments of debt | -5.88%-108K | 38.81%-82K | 52.61%-400K | 69.27%-59K | 52.49%-105K | 52.78%-102K | 37.67%-134K | -6.43%-844K | 4.95%-192K | -11.06%-221K |
| Net common stock issuance | 1,095,300.00%10.95M | -50.95%181K | -73.86%14.38M | -51.98%13.77M | -8.95%234K | -100.34%-1K | -98.57%369K | 193.59%54.99M | 257.13%28.69M | --257K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 10,628.16%10.84M | -57.87%99K | -74.19%13.98M | -51.87%13.72M | 258.33%129K | -230.38%-103K | -99.08%235K | 210.52%54.15M | 263.90%28.49M | 118.09%36K |
| Net cash flow | ||||||||||
| Beginning cash position | -71.09%7.38M | -52.24%16.12M | 362.58%33.76M | -29.97%9.06M | -15.22%16.33M | -1.39%25.53M | 362.58%33.76M | -48.34%7.3M | 126.82%12.94M | 68.89%19.26M |
| Current changes in cash | 139.03%3.57M | -6.46%-8.75M | -166.32%-17.56M | -66.30%7.02M | -14.20%-7.2M | -37.85%-9.16M | -144.21%-8.22M | 534.82%26.47M | 1,555.64%20.83M | -0.46%-6.3M |
| Effect of exchange rate changes | --0 | 166.67%6K | -627.27%-80K | 757.14%46K | -407.69%-66K | -1,120.00%-51K | -325.00%-9K | 98.51%-11K | -102.08%-7K | -102.25%-13K |
| End cash Position | -32.89%10.96M | -71.09%7.38M | -52.24%16.12M | -52.24%16.12M | -29.97%9.06M | -15.22%16.33M | -1.39%25.53M | 362.58%33.76M | 362.58%33.76M | 126.82%12.94M |
| Free cash flow | 19.23%-7.33M | -5.97%-8.97M | -14.32%-31.64M | 12.40%-6.73M | -16.69%-7.37M | -34.90%-9.07M | -21.80%-8.47M | -17.13%-27.67M | -16.83%-7.69M | -2.97%-6.32M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg